Company: Thermo Fisher Scientific Inc.
Ticker: TMO
Form: 10-K
Filed: 2026-02-26
Fiscal Period: {"fp": "FY", "fy_curr": 2025, "fy_prev": 2024}

Question: By what percentage did Thermo Fisher Scientific Inc.'s operating income change from fiscal year 2024 to fiscal year 2025?
Question Type: temporal_comparison

Concept: OperatingIncomeLoss
Answer (Numeric): 5.57
Answer (Display): 5.57%
Unit: percent_change

Evidence:
[{"chunk_id": "118", "equivalent_chunk_ids": ["118"], "section": "CONSOLIDATED STATEMENTS OF INCOME", "supports": ["current", "previous"], "text": "Year Ended\nDecember 31,\n(In millions except per share amounts)\nRevenues\nProduct revenues\n25,965\n25,034\n25,243\nService revenues\n18,592\n17,845\n17,614\nTotal revenues\n44,556\n42,879\n42,857\nCosts and operating expenses:\nCost of product revenues\n13,405\n12,523\n13,168\nCost of service revenues\n12,913\n12,654\n12,589\nSelling, general and administrative expenses\n8,732\n8,595\n8,445\nResearch and development expenses\n1,397\n1,390\n1,337\nRestructuring and other costs\nTotal costs and operating expenses\n36,810\n35,542\n35,998\nOperating income\n7,746\n7,337\n6,859\nInterest income\n1,078\nInterest expense\n1,419\n1,390\n1,375\nOther income/(expense)\nIncome before income taxes\n7,308\n7,037\n6,298\nBenefit from/(provision for) income taxes\nEquity in earnings/(losses) of unconsolidated entities\nNet income\n6,721\n6,338\n5,955\nLess: net income/(loss) attributable to noncontrolling interests and redeemable noncontrolling interest\nNet income attributable to Thermo Fisher Scientific Inc.\n6,704\n6,335\n5,995\nEarnings per share attributable to Thermo Fisher Scientific Inc.\nBasic\n17.77\n16.58\n15.52\nDiluted\n17.74\n16.53\n15.45\nWeighted average shares\nBasic\nDiluted\nThe accompanying notes are an integral part of these consolidated financial statements.\nTHERMO FISHER SCIENTIFIC INC."}]

Derivation: {"current_value": 7746.0, "op": "pct_change", "previous_value": 7337.0}